PAR1-stimulated platelet releasate promotes angiogenic activities of endothelial progenitor cells more potently than PAR4-stimulated platelet releasate

被引:28
作者
Huang, Z. [1 ]
Miao, X. [1 ]
Luan, Y. [2 ]
Zhu, L. [1 ]
Kong, F. [2 ]
Lu, Q. [3 ]
Pernow, J. [4 ]
Nilsson, G. [5 ]
Li, N. [1 ,6 ]
机构
[1] Karolinska Univ, Karolinska Inst, Hosp Solna, Clin Pharmacol Unit,Dept Med Solna, SE-17176 Stockholm, Sweden
[2] Shandong Univ, Hosp 2, Cent Lab, Jinan 250100, Peoples R China
[3] Shandong Univ, Hosp 2, Dept Cardiol, Jinan 250100, Peoples R China
[4] Karolinska Univ, Karolinska Inst, Hosp Solna, Cardiol Unit,Dept Med Solna, SE-17176 Stockholm, Sweden
[5] Karolinska Univ, Karolinska Inst, Hosp Solna, Clin Immunol & Allergy Unit,Dept Med Solna, SE-17176 Stockholm, Sweden
[6] Shandong Univ, Shandong Univ Karolinska Inst Collaborat Lab Stem, Jinan 250100, Peoples R China
基金
瑞典研究理事会;
关键词
angiogenesis modulators; endothelial progenitor cells; platelets; stem cells; thrombin; ALPHA-GRANULES; REGULATORY PROTEINS; VEGF;
D O I
10.1111/jth.12815
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundEndothelial progenitor cells (EPCs) are important for endothelial regeneration and angiogenesis. Thrombin protease-activated receptor 1 (PAR1) PAR1 and PAR4 stimulation induces selective release of platelet proangiogenic and antiangiogenic regulators. ObjectiveTo investigate if PAR1-stimulated platelet releasate (PAR1-PR) and PAR4-PR regulate angiogenic properties of EPCs in different manners. Methods and ResultsEPCs were generated from peripheral mononuclear cell culture. Washed platelets (2x10(9) mL(-1)) were stimulated by PAR1-activating peptide (PAR1-AP; 10mol L-1) or PAR4-AP (100mol L-1) to prepare PAR1-PR and PAR4-PR, respectively. PAR1-PR or PAR4-PR had little influence on EPC proliferation. EPC migration experiments using a modified Boyden chamber showed that both platelet releasates facilitated EPC migration. As for in vitro tube formation on Matrigel, PAR1-PR and PAR4-PR similarly enhanced capillary-like network formation of EPCs in the complete EPC medium containing 10% FBS and a cocktail of growth factors, while PAR1-PR more profoundly increased EPC tube formation in basal culture medium supplemented with only 0.5% FBS than did PAR4-PR. The latter was confirmed in the murine angiogenesis model of subcutaneous Matrigel implantation. Moreover, blockade of vascular endothelial growth factor, stromal cell-derived factor 1, or matrix metalloproteinases attenuated EPC migration and tube formation, suggesting a cooperation of these factors in the enhancements. ConclusionsPAR1-PR enhances vasculogenesis more potently than PAR4-PR, and the enhancements require a cooperation of multiple platelet-derived angiogenic regulators.
引用
收藏
页码:465 / 476
页数:12
相关论文
共 34 条
[1]   Isolation of putative progenitor endothelial cells for angiogenesis [J].
Asahara, T ;
Murohara, T ;
Sullivan, A ;
Silver, M ;
vanderZee, R ;
Li, T ;
Witzenbichler, B ;
Schatteman, G ;
Isner, JM .
SCIENCE, 1997, 275 (5302) :964-967
[2]   Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology [J].
Banks, RE ;
Forbes, MA ;
Kinsey, SE ;
Stanley, A ;
Ingham, E ;
Walters, C ;
Selby, PJ .
BRITISH JOURNAL OF CANCER, 1998, 77 (06) :956-964
[3]   MiR-223 downregulation promotes glomerular endothelial cell activation by upregulating importin α4 and α5 in IgA nephropathy [J].
Bao, Hao ;
Chen, Hao ;
Zhu, Xiaodong ;
Zhang, Minchao ;
Yao, Genhong ;
Yu, Yusheng ;
Qin, Weisong ;
Zeng, Caihong ;
Zen, Ke ;
Liu, Zhihong .
KIDNEY INTERNATIONAL, 2014, 85 (03) :624-635
[4]   Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis [J].
Battinelli, Elisabeth M. ;
Markens, Beth A. ;
Italiano, Joseph E., Jr. .
BLOOD, 2011, 118 (05) :1359-1369
[5]   Pericyte Regulation of Vascular Remodeling Through the CXC Receptor 3 [J].
Bodnar, Richard J. ;
Rodgers, Margaret E. ;
Chen, William C. W. ;
Wells, Alan .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (12) :2818-2829
[6]   Differential role of platelet granular mediators in angiogenesis [J].
Brill, A ;
Elinav, H ;
Varon, D .
CARDIOVASCULAR RESEARCH, 2004, 63 (02) :226-235
[7]   Improvement of antiangiogenic cancer therapy by understanding the mechanisms of angiogenic factor interplay and drug resistance [J].
Cao, Yihai ;
Zhong, Weide ;
Sun, Yan .
SEMINARS IN CANCER BIOLOGY, 2009, 19 (05) :338-343
[8]   Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuli [J].
Chatterjee, Madhumita ;
Huang, Zhangsen ;
Zhang, Wei ;
Jiang, Lei ;
Hultenby, Kjell ;
Zhu, Linjing ;
Hu, Hu ;
Nilsson, Gunnar P. ;
Li, Nailin .
BLOOD, 2011, 117 (14) :3907-3911
[9]   Microparticles: major transport vehicles for distinct microRNAs in circulation [J].
Diehl, Philipp ;
Fricke, Alba ;
Sander, Laura ;
Stamm, Johannes ;
Bassler, Nicole ;
Htun, Nay ;
Ziemann, Mark ;
Helbing, Thomas ;
El-Osta, Assam ;
Jowett, Jeremy B. M. ;
Peter, Karlheinz .
CARDIOVASCULAR RESEARCH, 2012, 93 (04) :633-644
[10]   PRESERVATION OF VASCULAR INTEGRITY IN ORGANS PERFUSED IN VITRO WITH A PLATELET-RICH MEDIUM [J].
GIMBRONE, MA ;
ASTER, RH ;
COTRAN, RS ;
CORKERY, J ;
JANDL, JH ;
FOLKMAN, J .
NATURE, 1969, 222 (5188) :33-+